Comments
Loading...
Zevra Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ZVRA | Benzinga
Zevra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.480
Quarterly Revenue Estimate
$29.35M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$23.61M
Analyze the earnings history of Zevra Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics | -$0.40 | $0.48 | — | — | $3.42M | $29.35M | — | — | 05/07/2025 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.51 | -$0.40 | -$0.67 | -67.50% | $13.22M | $8.93M | $12.00M | 34.38% | 03/11/2025 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.30 | -$0.42 | -$0.69 | -64.29% | $2.90M | $4.87M | $3.69M | -24.13% | 11/12/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.08 | -$0.44 | -$0.48 | -9.09% | $8.47M | $4.41M | $4.45M | 0.88% | 08/13/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.34 | -$0.48 | -$0.40 | 16.67% | $2.88M | $3.76M | $3.42M | -8.91% | 05/08/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.26 | -$0.27 | -$0.40 | -48.15% | $2.30M | $11.74M | $13.22M | 12.58% | 03/28/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.19 | -$0.30 | -$0.40 | -33.33% | $2.87M | $3.38M | $2.90M | -14.35% | 11/07/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.19 | -$0.39 | -$0.15 | 61.54% | $1.30M | $2.90M | $8.47M | 192.07% | 08/14/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.05 | -$0.23 | -$0.34 | -47.83% | $3.96M | $2.65M | $2.88M | 8.64% | 05/15/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.08 | -$0.17 | -$0.26 | -52.94% | $2.60M | $3.20M | $2.30M | -28.12% | 03/07/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.06 | -$0.13 | -$0.19 | -46.15% | $1.97M | $3.20M | $2.87M | -10.19% | 11/09/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.40 | -$0.12 | -$0.19 | -58.33% | $11.99M | $1.80M | $1.30M | -27.78% | 08/11/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | -$1.61 | -$0.05 | -$0.05 | 0.00% | $12.10M | $3.06M | $3.96M | 29.58% | 05/12/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | — | -$0.07 | -$0.08 | -14.29% | — | $2.23M | $2.60M | 16.59% | 03/30/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | — | -$0.07 | -$0.06 | 14.29% | — | $2.18M | $1.97M | -9.86% | 11/10/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | $0.01 | $0.22 | -$0.40 | -281.82% | $6.91M | $12.10M | $11.99M | -0.94% | 08/12/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.12 | -$0.17 | -$1.61 | -847.06% | $2.09M | $2.10M | $12.10M | 476.19% | 05/13/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.18 | -$0.64 | -$1.07 | -67.19% | $1.38M | $2.00M | $2.37M | 18.30% | 03/11/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.33 | — | $0.01 | — | $0.00 | $6.75M | $6.91M | 2.34% | 08/12/2020 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.46 | — | -$0.12 | — | $0.00 | $5.80M | $2.09M | -63.98% | 05/12/2020 | Get Alert |
Zevra Therapeutics (ZVRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.67 | $-0.40 | -67.5 % |
| Q3 | 2024-11-12 | $-0.69 | $-0.42 | -64.3 % |
| Q2 | 2024-08-13 | $-0.48 | $-0.44 | -9.09 % |
| Q1 | 2024-05-08 | $-0.40 | $-0.48 | 16.7 % |
Zevra Therapeutics (ZVRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $12.00M | $8.93M | 34.4 % |
| Q3 | 2024-11-12 | $3.70M | $4.87M | -24.1 % |
| Q2 | 2024-08-13 | $4.45M | $4.41M | 0.88 % |
| Q1 | 2024-05-08 | $3.43M | $3.76M | -8.91 % |
FAQ
When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?
Zevra Therapeutics (ZVRA) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Zevra Therapeutics (NASDAQ:ZVRA)?
The Actual EPS was $-0.67, which missed the estimate of $-0.40.
What were Zevra Therapeutics’s (NASDAQ:ZVRA) revenues?
The Actual Revenue was $12M, which beat the estimate of $8.9M.
Browse earnings estimates, EPS, and revenue on all stocks.